LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Capital expenditures 2016–2025
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$13.4MFY2025 · since FY2016: $39.7M → $13.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.4M | -27.1% |
| FY2024 | $18.4M | — |
| FY2022 | $26.2M | +36.1% |
| FY2021 | $19.3M | +57.7% |
| FY2020 | $12.2M | -72.7% |
| FY2019 | $44.7M | +33.2% |
| FY2018 | $33.6M | +46.0% |
| FY2017 | $23.0M | -42.1% |
| FY2016 | $39.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice